Frequency of measuring body weight in (sub)populations of patients with cancer treated with chemotherapy.
Shirley KempsMostafa SoleymanHarmen HulsMariette LabotsMirjam CrulPublished in: European journal of hospital pharmacy : science and practice (2022)
Our observations from real-world data indicate it is safe to omit the current requirement for monthly weight measurements. We advise that during chemotherapy, measuring the body weight in patients who have acute leukaemia, lymphoma or pancreatic cancer or who are under 20 years of age, should be performed at least every 3 months. For other patients, extending this period to a 6-monthly weight measurement should be considered.
Keyphrases
- body weight
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- body mass index
- weight loss
- locally advanced
- squamous cell carcinoma
- intensive care unit
- diffuse large b cell lymphoma
- hepatitis b virus
- rectal cancer
- deep learning
- drug induced
- extracorporeal membrane oxygenation
- data analysis
- genetic diversity